Zantac Cancer

Zantac Cancer

Did Zantac (Ranitidine) Cause Your Cancer?

Millions of Americans use the drug ranitidine, commonly known as Zantac, to relieve stomach ulcers and heartburn. In September 2019, the U.S. Food and Drug Administration (FDA), released a statement warning that over-the-counter varieties of Zantac contained low levels of the probable human carcinogen n-nitrosodimethylamine, also known as NDMA, and announced a voluntary recall of certain ranitidine drugs.  In April 2020, the FDA took the ultimate step and asked manufacturers to remove all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.

About Ranitidine Recall

New findings from the FDA suggest that impurities in the drug may increase over time and when exposed to temperatures higher than room temperature. Prior to the April 2020 announcement, drug companies Sandoz and Apotex recalled their generic ranitidine products sold in the United States. That recall included Zantac 150, Zantac 150 Cool Mint, and Zantac 75.

Zantac Cancer Concerns

NDMA exposure has been linked to various primary cancers, including:

  • Liver cancer
  • Lung cancer
  • Esophageal cancer
  • Pancreatic cancer
  • Liver cancer
  • Kidney cancer
  • Bladder cancer
  • Colorectal cancer
  • Stomach cancer

Ranitidine users with NDMA-related cancer may be able to file a Zantac lawsuit.

Cancer is serious and can prevent you from living the life you are used to. This leads to frustration and uncertainty about the future. At times, it feels as though you have more questions than answers. How will I pay my medical bills? How will I support my family while I recover? Should I seek legal help for a Zantac lawsuit?

At Allen & Allen, we know your concerns can be overwhelming, but rest assured that throughout your case, our dedicated team will be with you every step of the way. We’re committed to protecting our clients throughout their recovery and will fight for your fair treatment and compensation.

Know Your Rights

The attorneys at Allen & Allen represent people from across the country in personal injury and wrongful death cases related to Zantac cancer. You may have the right to recover monetary damages if you or a loved one have suffered due to exposure to NDMA found in recalled Zantac and ranitidine medications. Damages may include reimbursement or compensation for:

  • Current medical costs
  • Future medical costs
  • Pain, suffering and inconvenience
  • Lost wages
  • Loss of economic opportunity

You can help protect yourself by contacting an attorney at Allen & Allen to discuss your situation. If you have a case, our experienced attorneys can help you:

  • Recover damages you are entitled to from the negligent drug manufacturer
  • Obtain a fair settlement offer for damages through negotiation
  • Collect evidence that may be needed to protect your claim for appropriate financial compensation.

Why Choose Allen & Allen?

While the circumstances behind every case are different, one fact holds true for all – the right attorney is a necessity to ensure you receive the support you need.

Allen & Allen is a law firm built on compassionate service and aggressive advocacy. We are committed to protecting our clients through their recovery and will fight for your fair treatment and compensation.

If you or a loved one used Zantac and have been diagnosed with cancer, the attorneys at Allen & Allen can help you recover the compensation you deserve. You can discuss your unique situation at no cost by calling us today or filling out our contact form.

 

Injury Types

Wrongful Death

The death of a family member due to a fatal accident caused by someone else's negligence can be emotionally and financially devastating. While families are left trying to cope with a tragedy, Allen & Allen can help you recover damages through reimbursement or compensation for the dramatic changes that will follow.

COVID-19 Update

  • March 27, 2020
  • News

We hope this message finds you well and your family and friends healthy. We are all adjusting to a new normal in these unprecedented times, and we continue to be...

Update: FDA Requests Immediate Removal of All Ranitidine Products (Zantac and Generic) from the Market

  • April 2, 2020
  • News

On April 1, 2020, the U.S. Food and Drug Administration (FDA) announced an immediate withdrawal of all products containing ranitidine.  This marks a significant milestone in the agency’s ongoing investigation...

Ranitidine (Found in Zantac) Linked to Cancer

  • January 10, 2020
  • Blog

In late 2019, drug maker, Sanofi, announced a voluntary recall of their over-the-counter (OTC) acid reflux medication, Zantac. The recall was issued in part due to a U.S. Food and...